[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341017-105":59,"doc-detail-341017-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","evaluating-synergistic-effects-of-metformin-and-simvastatin-on-ovarian-cancer-cells-research-article","Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells - research article","","Ovarian cancer is highlighted as the most lethal gynecological malignancy, with low survival linked to delayed diagnosis and platinum resistance. The study investigates drug repurposing by testing whether metformin (MTF) and simvastatin (SIM) work synergistically against ovarian cancer cells. Combination effects were evaluated on OVCAR-3 and SKOV-3 proliferation and viability, using IC50 determination and subtoxic dosing, with transcriptomic profiling and real-time PCR validation. Results show synergistic inhibition and coordinated dysregulation of key AMPK/mTOR regulators.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/evaluating-synergistic-effects-of-metformin-and-simvastatin-on-ovarian-cancer-cells-research-article/341017/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/evaluating-synergistic-effects-of-metformin-and-simvastatin-on-ovarian-cancer-cells-research-article/341017.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of the study on metformin and simvastatin?","Question",{"text":112,"@type":113},"To explore molecular mechanisms supporting potential synergistic anti-cancer effects of metformin (MTF) and simvastatin (SIM) on ovarian cancer cells.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which cell lines and assays were used to assess the combination effects?",{"text":117,"@type":113},"The study evaluated proliferation and viability in OVCAR-3 and SKOV-3, using IC50 determination with proliferation assays followed by subtoxic concentration treatments; transcriptomic analysis was performed on treated OVCAR-3 cells and validated by real-time PCR in both cell lines.",{"name":119,"@type":110,"acceptedAnswer":120},"What evidence supports synergy between MTF and SIM?",{"text":121,"@type":113},"Cytotoxicity-guided concentration selection (MTF 10 mM, SIM 5 μM) showed a synergistic inhibition of proliferation and viability in both cell lines, alongside differential gene regulation and consistent real-time PCR validation.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},341017,1790739884,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","PLOS ONE  \nOPEN ACCESS  \nCitation: Mikhael S, Kurdi A, Khoueiry-Zgheib N, Tahtouh R, Nasr R, Hilal G (2024) Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells. PLoS ONE 19(3): e0298127 .  \n[https://doi.org/10.1371/journal.pone.0298127](https://doi.org/10.1371/journal.pone.0298127)  \n[Editor:](Editor: Chien-Feng Li)[ Chien-Feng Li](Editor: Chien-Feng Li), National Institute of Cancer Research, TAIWAN  \nReceived: November 20, 2023  \nAccepted: January 19, 2024  \nPublished: March 15, 2024  \nCopyright: © 2024 Mikhael et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nData Availability Statement: All relevant data are within the manuscript and its Supporting information files.  \nFunding: Centre national de la recherche scientifique (CNRS) provided minor funding for my years at the university. The funders had no role in study design, data analysis, decision to publish, or preparation of the manuscript.  \nCompeting interests: The authors have declared that no competing interests exist.  \nRESEARCH ARTICLE  \nEvaluating synergistic effects of metformin and simvastatin on ovarian cancer cells  \nSara Mikhael1, Abdullah Kurdi2, Nathalie Khoueiry-Zgheib3, Roula Tahtouh1, Rihab Nasr4 *, George Hilal1 *  \n1 Laboratory of Cancer and Metabolism, Faculty of Medicine, Saint-Joseph University, Beirut, Lebanon,  \n2 Department of Biochemistry and Molecular Genetics, Faculty of Medicine, American University of Beirut, Beirut, Lebanon, 3 Department of Pharmacology and Toxicology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon, 4 Department of Anatomy, Cell Biology, and Physiological Sciences, Faculty of Medicine, American University of Beirut, Beirut, Lebanon  \n* [george.hilal@usj.edu.lb](george.hilal@usj.edu.lb) (GH); [rn03@aub.edu.lb](rn03@aub.edu.lb) (RN)  \nAbstract  \nBackground  \nOvarian Cancer (OC) stands as the most lethal gynecological malignancy, presenting an urgent clinical challenge in the quest to improve response rates. One approach to address this challenge is through drug repurposing , exemplified by the investigation of metabolicmodulating drugs such as Metformin (MTF) and Simvastatin (SIM) . This study aims to explore the molecular mechanisms contributing to the potential synergistic anti-cancer effects between MTF and SIM on ovarian cancer cells.  \nMethods  \nWe assessed the effects of the combination on the proliferation and viability of two cell lines OVCAR-3 and SKOV-3 . IC50 concentrations of MTF and SIM were determined using a proliferation assay, followed by subtoxic concentrations to explore the potential synergistic effects on the viability of both cell lines. Transcriptomic analysis was conducted on OVCAR- 3 treated cells, and the findings were validated by assessing the expression levels of differentially expressed genes (DEGs) through real-time PCR in both cell lines SK-OV-3 and OVCAR-3 .  \nResults  \nCytotoxicity analysis guided the selection of treatment concentrations as such MTF 10 mM and SIM 5 μM. The combined treatment of MTF and SIM demonstrated a synergistic inhibition of proliferation and viability in both cell lines. In OVCAR-3, exclusive identification of 507 DEGs was seen in the combination arm. Upregulation of FOXO3, RhoA, and TNFα , along with downregulation of PIK3R1, SKP2, and ATP6V1D levels, was observed in OVCAR-3 treated cells. Real-time PCR validation confirmed the consistency of expression levels for the mentioned DEGs.  \nConclusion  \nOur data strongly supports the presence of synergy between MTF and SIM in OC cells. The combination’s effect is associated with the dysregulation of genes in the key regulators AMPK and mTOR alongside other interconnected pathways.  \nIntroduction  \nOvarian Cancer (OC) stands as the most lethal gynecological malignancy and ranks amo","cbCainhM9qrJc93s","https://ap.wps.com/l/cbCainhM9qrJc93s","pdf",3014976,21,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n# Introduction","[{\"question\":\"What is the main goal of the study on metformin and simvastatin?\",\"answer\":\"To explore molecular mechanisms supporting potential synergistic anti-cancer effects of metformin (MTF) and simvastatin (SIM) on ovarian cancer cells.\"},{\"question\":\"Which cell lines and assays were used to assess the combination effects?\",\"answer\":\"The study evaluated proliferation and viability in OVCAR-3 and SKOV-3, using IC50 determination with proliferation assays followed by subtoxic concentration treatments; transcriptomic analysis was performed on treated OVCAR-3 cells and validated by real-time PCR in both cell lines.\"},{\"question\":\"What evidence supports synergy between MTF and SIM?\",\"answer\":\"Cytotoxicity-guided concentration selection (MTF 10 mM, SIM 5 μM) showed a synergistic inhibition of proliferation and viability in both cell lines, alongside differential gene regulation and consistent real-time PCR validation.\"}]","Evaluating synergistic effects of metformin and simvastatin on ovarian cancer cells - research article | PDF",1790039955,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/43d8e5bb88bebe0cd8d0b339b3558946.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/45dadb4250b5af19b70046f6bbfb4143.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf9b351cb3091055c8bf3ec9aa0e8578.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0906439273831bc6e34bc777e7c7c974.webp",980,1268]